As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. Our AtriClip Left Atrial Appendage Exclusion System products are the most widely used LAA management devices worldwide. Our Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients, and our cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
We are passionately focused on healing the lives of those affected by Afib and pain after surgery.
We work to heal the lives of Patients, empower our People, and collaborate with our Partners to reduce the burden of Afib worldwide.
At AtriCure, patients are at the heart of what we do every day. Each and every AtriCure team member knows that regardless of their position, they are positively impacting patients’ lives. Our teams are comprised of talented and passionate people who embrace our mission of reducing the global Afib epidemic. Our influence is worldwide, including offices in the US and Europe. Join our team!